RGNX
Regenxbio·NASDAQ
--
--(--)
--
--(--)
RGNX Filings
Filing Date
Form Description
Form Type
2026-03-20
Form 8-K - Current report
Key Events
2026-03-20 · Key Events
Form 8-K - Current report
2026-03-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-10
Form 144 - Report of proposed sale of securities
Ownership
2026-03-10 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-05
REGENXBIO Inc.(RGNX)-20260305-2025 Q4 Earnings call transcript
Earnings Call
2026-03-05 · Earnings Call
REGENXBIO Inc.(RGNX)-20260305-2025 Q4 Earnings call transcript
2026-03-05
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-05 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-05
Form 8-K - Current report
Key Events
2026-03-05 · Key Events
Form 8-K - Current report
2026-02-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-10
Form 8-K - Current report
Key Events
2026-02-10 · Key Events
Form 8-K - Current report
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
